Chris is Chief Investigator of the IBD-RESPONSE study. He is a Senior Lecturer within the Translational & Clinical Research Institute at Newcastle University and an Honorary Consultant in Gastroenterology at the Newcastle upon Tyne Hospitals specialising in management of inflammatory bowel disease.
Chris is a group lead with a research laboratory team studying molecular mucosal immunology, the gut microbiome, drug discovery and precision medicine in Crohn's disease and ulcerative colitis.
Chris is a Wellcome Trust Sir Henry Dale Fellow & Lister Institute Prize Fellow within the Translational & Clinical Research Institute at Newcastle University.
Chris leads a research group focused on multi-omic computational and experimental approaches to study microbial-host interaction in the gut, to determine mechanisms of health and gastrointestinal diseases.
Ally is a Consultant Gastroenterologist at the Newcastle upon Tyne Hospitals NHS Foundation Trust and Associate Clinical Lecturer within the Translational & Clinical Research Institute at Newcastle University.
Ally's clinical and research interests include therapeutics in inflammatory bowel disease.
Nicola is an Academic Clinical Fellow in gastroenterology, with an interest in inflammatory bowel disease. She is an Associate PI for IBD-RESPONSE.
To find out more about the Associate PI scheme, follow the link below.
Katherine is the Patient and Public Involvement and Engagement (PPIE) Manager for the NIHR Newcastle Biomedical Research Centre’s Informatics and Precision Care Theme.
She is responsible for making sure that patients and the public are meaningfully involved in IBD-RESPONSE to ensure the research is meeting the patient need. Katherine has worked in PPIE since 2016.
Naomi is the Senior Trial Manager for IBD-RESPONSE and provides oversight and support to the study management group ensuring that the study is conducted in line with sponsor, regulatory and research governance requirements
Dean is a Trial Co-Manager, co-managing the IBD-RESPONSE study. Dean works closely with site staff to respond to queries concerning any aspects of the study.
Victoria is Trial Co-Manager for IBD-RESPONSE study, making sure the study is compliant with the study protocol and international standards of Good Clinical Practice (GCP).
Sonya is a data manager for IBD-RESPONSE. She has a background biological research and extensive administrative experience in both the private and public sectors.
Kath is a Clinical Trial Administrator for IBD-RESPONSE.
Sarah has a background in Administration and Events Management and now the Clinical Trials Administrator for IBD-RESPONSE.